Overview
The LS10 peptide, available in a 1 mg quantity, serves as a highly selective ligand for glioma-targeting drug delivery. It demonstrates a unique ability to bind specifically to NG2 protein, which is significantly overexpressed in glioma cells while remaining restricted in normal tissue. This characteristic makes LS10 an essential tool for researchers focused on developing targeted therapies for glioma and other related cancers. By choosing LS10, you align your research with a peptide designed for precision and efficacy in drug delivery applications.
Key Features
- Highly selective binding to NG2 protein
- Targeted glioma drug delivery applications
- Available in a 1 mg size for flexibility
- Ideal for research in oncology and drug discovery
- Compatible with various labeling techniques
Specifications
| Property | Details |
|---|---|
| Weight | 1 mg |
| Form | Lyophilized powder |
| Storage | -20°C for long-term |
FAQ
How does the LS10 peptide specifically target glioma cells?
LS10 peptide targets glioma cells by binding to the NG2 protein, which is notably overexpressed in these tumor cells. This selective binding enables more effective drug delivery to the tumor site, improving therapeutic outcomes.
Can LS10 peptide be used with other labeling kits?
Yes, LS10 is compatible with various labeling techniques, including those found in our comprehensive peptide and protein labeling kits. You can enhance your research versatility by integrating LS10 with our other products, such as PKG substrate or Autocamtide-2.
What are the storage conditions for LS10 peptide?
For optimal stability, store the LS10 peptide at -20°C. This ensures the integrity of the peptide and maintains its binding efficacy for your experimental needs.
When you’re ready to advance your research, consider the LS10 peptide as a crucial component for glioma-targeting studies. Its specific binding capabilities paired with our extensive range of peptides available in our catalog make it an excellent choice for researchers in this field. Make your purchase today and enhance your understanding of glioma-targeting strategies.




Reviews
There are no reviews yet.